,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,22283,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0000017,Prostaglandin G/H synthase 1,https://www.drugbank.ca/bio_entities/BE0000017,P23219,Prostaglandin G/H synthase 1,5742.0,PTGS1,9606,Homo sapiens (human),Inhibitor,,,PMID:14746879|PMID:15035793|PMID:15840771|PMID:15871445|PMID:16368818|PMID:5284360|PMID:11752352,https://www.ncbi.nlm.nih.gov/pubmed/14746879|https://www.ncbi.nlm.nih.gov/pubmed/15035793|https://www.ncbi.nlm.nih.gov/pubmed/15840771|https://www.ncbi.nlm.nih.gov/pubmed/15871445|https://www.ncbi.nlm.nih.gov/pubmed/16368818|https://www.ncbi.nlm.nih.gov/pubmed/5284360|https://www.ncbi.nlm.nih.gov/pubmed/11752352,14746879|15035793|15840771|15871445|16368818|5284360|11752352,,"Moon C, Ahn M, Jee Y, Heo S, Kim S, Kim H, Sim KB, Koh CS, Shin YG, Shin T: Sodium salicylate-induced amelioration of experimental autoimmune encephalomyelitis in Lewis rats is associated with the suppression of inducible nitric oxide synthase and cyclooxygenases. Neurosci Lett. 2004 Feb 12;356(2):123-6.|Graham GG, Scott KF: Mechanisms of action of paracetamol and related analgesics. Inflammopharmacology. 2003;11(4):401-13.|Sun R, Carlson NG, Hemmert AC, Kishore BK: P2Y2 receptor-mediated release of prostaglandin E2 by IMCD is altered in hydrated and dehydrated rats: relevance to AVP-independent regulation of IMCD function. Am J Physiol Renal Physiol. 2005 Sep;289(3):F585-92. Epub 2005 Apr 19.|Celik G, Pasaoglu G, Bavbek S, Abadoglu O, Dursun B, Mungan D, Misirligil Z: Tolerability of selective cyclooxygenase inhibitor, celecoxib, in patients with analgesic intolerance. J Asthma. 2005 Mar;42(2):127-31.|Liu X, Lee TL, Wong PT: Cyclooxygenase-1 inhibition shortens the duration of diazepam-induced loss of righting reflex in mice. Anesth Analg. 2006 Jan;102(1):135-40.|Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232-5.|Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5."
1,22284,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0000262,Prostaglandin G/H synthase 2,https://www.drugbank.ca/bio_entities/BE0000262,P35354,Prostaglandin G/H synthase 2,5743.0,PTGS2,9606,Homo sapiens (human),Inhibitor,,,PMID:15035793|PMID:15070163|PMID:15106733|PMID:15199473|PMID:15348270|PMID:5284360|PMID:17259377,https://www.ncbi.nlm.nih.gov/pubmed/15035793|https://www.ncbi.nlm.nih.gov/pubmed/15070163|https://www.ncbi.nlm.nih.gov/pubmed/15106733|https://www.ncbi.nlm.nih.gov/pubmed/15199473|https://www.ncbi.nlm.nih.gov/pubmed/15348270|https://www.ncbi.nlm.nih.gov/pubmed/5284360|https://www.ncbi.nlm.nih.gov/pubmed/17259377,15035793|15070163|15106733|15199473|15348270|5284360|17259377,,"Graham GG, Scott KF: Mechanisms of action of paracetamol and related analgesics. Inflammopharmacology. 2003;11(4):401-13.|Fiebich BL, Chrubasik S: Effects of an ethanolic salix extract on the release of selected inflammatory mediators in vitro. Phytomedicine. 2004 Feb;11(2-3):135-8.|Chae HJ, Chae SW, Reed JC, Kim HR: Salicylate regulates COX-2 expression through ERK and subsequent NF-kappaB activation in osteoblasts. Immunopharmacol Immunotoxicol. 2004 Feb;26(1):75-91.|Wu KK: Aspirin and other cyclooxygenase inhibitors: new therapeutic insights. Semin Vasc Med. 2003 May;3(2):107-12.|Elvira C, Gallardo A, Lacroix N, Schacht E, San Roman J: Incorporation of salicylic acid derivatives to hydrophilic copolymer systems with biomedical applications. J Mater Sci Mater Med. 2001 Jun;12(6):535-42.|Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232-5.|Zheng L, Howell SJ, Hatala DA, Huang K, Kern TS: Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy. Diabetes. 2007 Feb;56(2):337-45."
2,22285,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0000126,Aldo-keto reductase family 1 member C1,https://www.drugbank.ca/bio_entities/BE0000126,Q04828,Aldo-keto reductase family 1 member C1,1645.0,AKR1C1,9606,Homo sapiens (human),Inhibitor,,,PMID:18045204,https://www.ncbi.nlm.nih.gov/pubmed/18045204,18045204,,"Dhagat U, Carbone V, Chung RP, Matsunaga T, Endo S, Hara A, El-Kabbani O: A salicylic acid-based analogue discovered from virtual screening as a potent inhibitor of human 20alpha-hydroxysteroid dehydrogenase. Med Chem. 2007 Nov;3(6):546-50."
3,22432,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0002793,Cytochrome P450 2C9,https://www.drugbank.ca/bio_entities/BE0002793,P11712,Cytochrome P450 2C9 ,1559.0,CYP2C9,9606,Homo sapiens (human),Substrate,,,PMID:19515014|PMID:25840124,https://www.ncbi.nlm.nih.gov/pubmed/19515014|https://www.ncbi.nlm.nih.gov/pubmed/25840124,19515014|25840124,,"Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1.|Bojic M, Sedgeman CA, Nagy LD, Guengerich FP: Aromatic hydroxylation of salicylic acid and aspirin by human cytochromes P450. Eur J Pharm Sci. 2015 Jun 20;73:49-56. doi: 10.1016/j.ejps.2015.03.015. Epub 2015 Mar 31."
4,22433,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0001066,Solute carrier family 22 member 6,https://www.drugbank.ca/bio_entities/BE0001066,Q4U2R8,Solute carrier family 22 member 6,9356.0,SLC22A6,9606,Homo sapiens (human),Inhibitor,,,PMID:10929807|PMID:12130730|PMID:10049739|PMID:11099697|PMID:10220563,https://www.ncbi.nlm.nih.gov/pubmed/10929807|https://www.ncbi.nlm.nih.gov/pubmed/12130730|https://www.ncbi.nlm.nih.gov/pubmed/10049739|https://www.ncbi.nlm.nih.gov/pubmed/11099697|https://www.ncbi.nlm.nih.gov/pubmed/10220563,10929807|12130730|10049739|11099697|10220563,,"Cihlar T, Ho ES: Fluorescence-based assay for the interaction of small molecules with the human renal organic anion transporter 1. Anal Biochem. 2000 Jul 15;283(1):49-55.|Takeda M, Khamdang S, Narikawa S, Kimura H, Hosoyamada M, Cha SH, Sekine T, Endou H: Characterization of methotrexate transport and its drug interactions with human organic anion transporters. J Pharmacol Exp Ther. 2002 Aug;302(2):666-71.|Race JE, Grassl SM, Williams WJ, Holtzman EJ: Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3). Biochem Biophys Res Commun. 1999 Feb 16;255(2):508-14.|Uwai Y, Saito H, Inui K: Interaction between methotrexate and nonsteroidal anti-inflammatory drugs in organic anion transporter. Eur J Pharmacol. 2000 Dec 1;409(1):31-6.|Apiwattanakul N, Sekine T, Chairoungdua A, Kanai Y, Nakajima N, Sophasan S, Endou H: Transport properties of nonsteroidal anti-inflammatory drugs by organic anion transporter 1 expressed in Xenopus laevis oocytes. Mol Pharmacol. 1999 May;55(5):847-54."
5,22434,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0003645,Solute carrier family 22 member 8,https://www.drugbank.ca/bio_entities/BE0003645,Q8TCC7,Solute carrier family 22 member 8,9376.0,SLC22A8,9606,Homo sapiens (human),Inhibitor,,,PMID:11306713|PMID:12130730|PMID:14762099,https://www.ncbi.nlm.nih.gov/pubmed/11306713|https://www.ncbi.nlm.nih.gov/pubmed/12130730|https://www.ncbi.nlm.nih.gov/pubmed/14762099,11306713|12130730|14762099,,"Cha SH, Sekine T, Fukushima JI, Kanai Y, Kobayashi Y, Goya T, Endou H: Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol. 2001 May;59(5):1277-86.|Takeda M, Khamdang S, Narikawa S, Kimura H, Hosoyamada M, Cha SH, Sekine T, Endou H: Characterization of methotrexate transport and its drug interactions with human organic anion transporters. J Pharmacol Exp Ther. 2002 Aug;302(2):666-71.|Ohtsuki S, Kikkawa T, Mori S, Hori S, Takanaga H, Otagiri M, Terasaki T: Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of blood-brain barrier. J Pharmacol Exp Ther. 2004 Jun;309(3):1273-81. Epub 2004 Feb 4."
6,22435,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0000879,Solute carrier family 22 member 11,https://www.drugbank.ca/bio_entities/BE0000879,Q9NSA0,Solute carrier family 22 member 11,55867.0,SLC22A11,9606,Homo sapiens (human),Inhibitor,,,PMID:10660625,https://www.ncbi.nlm.nih.gov/pubmed/10660625,10660625,,"Cha SH, Sekine T, Kusuhara H, Yu E, Kim JY, Kim DK, Sugiyama Y, Kanai Y, Endou H: Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem. 2000 Feb 11;275(6):4507-12."
7,22436,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0001042,Solute carrier organic anion transporter family member 2B1,https://www.drugbank.ca/bio_entities/BE0001042,O94956,Solute carrier organic anion transporter family member 2B1 ,11309.0,SLCO2B1,9606,Homo sapiens (human),Substrate,,,PMID:15640378,https://www.ncbi.nlm.nih.gov/pubmed/15640378,15640378,,"Satoh H, Yamashita F, Tsujimoto M, Murakami H, Koyabu N, Ohtani H, Sawada Y: Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos. 2005 Apr;33(4):518-23. Epub 2005 Jan 7."
8,22437,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0000669,Monocarboxylate transporter 1,https://www.drugbank.ca/bio_entities/BE0000669,P53985,Monocarboxylate transporter 1,6566.0,SLC16A1,9606,Homo sapiens (human),Substrate,,,PMID:10579682,https://www.ncbi.nlm.nih.gov/pubmed/10579682,10579682,,"Tamai I, Sai Y, Ono A, Kido Y, Yabuuchi H, Takanaga H, Satoh E, Ogihara T, Amano O, Izeki S, Tsuji A: Immunohistochemical and functional characterization of pH-dependent intestinal absorption of weak organic acids by the monocarboxylic acid transporter MCT1. J Pharm Pharmacol. 1999 Oct;51(10):1113-21."
9,22602,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0003646,Solute carrier family 22 member 7,https://www.drugbank.ca/bio_entities/BE0003646,Q9Y694,Solute carrier family 22 member 7,10864.0,SLC22A7,9606,Homo sapiens (human),Substrate,,,PMID:12065749|PMID:9650585|PMID:11504818,https://www.ncbi.nlm.nih.gov/pubmed/12065749|https://www.ncbi.nlm.nih.gov/pubmed/9650585|https://www.ncbi.nlm.nih.gov/pubmed/11504818,12065749|9650585|11504818,,"Kobayashi Y, Ohshiro N, Shibusawa A, Sasaki T, Tokuyama S, Sekine T, Endou H, Yamamoto T: Isolation, characterization and differential gene expression of multispecific organic anion transporter 2 in mice. Mol Pharmacol. 2002 Jul;62(1):7-14.|Sekine T, Cha SH, Tsuda M, Apiwattanakul N, Nakajima N, Kanai Y, Endou H: Identification of multispecific organic anion transporter 2 expressed predominantly in the liver. FEBS Lett. 1998 Jun 12;429(2):179-82.|Morita N, Kusuhara H, Sekine T, Endou H, Sugiyama Y: Functional characterization of rat organic anion transporter 2 in LLC-PK1 cells. J Pharmacol Exp Ther. 2001 Sep;298(3):1179-84."
10,22603,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0000530,Serum albumin,https://www.drugbank.ca/bio_entities/BE0000530,P02768,Albumin,213.0,ALB,9606,Homo sapiens (human),Other/unknown,,,PMID:9275312|PMID:15768982|PMID:17320187|PMID:15819089,https://www.ncbi.nlm.nih.gov/pubmed/9275312|https://www.ncbi.nlm.nih.gov/pubmed/15768982|https://www.ncbi.nlm.nih.gov/pubmed/17320187|https://www.ncbi.nlm.nih.gov/pubmed/15819089,9275312|15768982|17320187|15819089,,"Bertucci C, Wainer IW: Improved chromatographic performance of a modified human albumin based stationary phase. Chirality. 1997;9(4):335-40.|Xiao HR, Sheng LQ, Shi CH, Xu XL, Xie YS, Liu QL: [Fluorescence study on the interaction of salicylic acid and bovine serum albumin]. Guang Pu Xue Yu Guang Pu Fen Xi. 2004 Jan;24(1):78-81.|Yin T, Wei W, Yang L, Liu K, Gao X: Kinetics parameter estimation for the binding process of salicylic acid to human serum albumin (HSA) with capacitive sensing technique. J Biochem Biophys Methods. 2007 Jun 10;70(4):587-93. Epub 2007 Jan 27.|Yu T, Tao Z: [Fluorescence study on the interaction of salicylic acid and human serum albumin]. Guang Pu Xue Yu Guang Pu Fen Xi. 1999 Jun;19(3):453-5."
11,22604,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0003652,Solute carrier family 22 member 10,https://www.drugbank.ca/bio_entities/BE0003652,Q63ZE4,Solute carrier family 22 member 10,387775.0,SLC22A10,9606,Homo sapiens (human),Inhibitor,,,PMID:15068970,https://www.ncbi.nlm.nih.gov/pubmed/15068970,15068970,,"Youngblood GL, Sweet DH: Identification and functional assessment of the novel murine organic anion transporter Oat5 (Slc22a19) expressed in kidney. Am J Physiol Renal Physiol. 2004 Aug;287(2):F236-44. Epub 2004 Apr 6."
12,32868,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606,Homo sapiens (human),,Ki (nM),9900.0,PMID:18579385,https://www.ncbi.nlm.nih.gov/pubmed/18579385,18579385,,
13,32869,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606,Homo sapiens (human),,Ki (nM),7100.0,PMID:18579385,https://www.ncbi.nlm.nih.gov/pubmed/18579385,18579385,,
14,32870,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,2920,Carbonic Anhydrase III,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2920,P07451,Carbonic anhydrase 3,761.0,CA3,9606,Homo sapiens (human),,Ki (nM),885000.0,PMID:18579385,https://www.ncbi.nlm.nih.gov/pubmed/18579385,18579385,,
15,32871,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,1247,Carbonic anhydrase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1247,P22748,Carbonic anhydrase 4,762.0,CA4,9606,Homo sapiens (human),,Ki (nM),11100.0,PMID:18579385,https://www.ncbi.nlm.nih.gov/pubmed/18579385,18579385,,
16,33051,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,1228,Carbonic Anhydrase VA,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1228,P35218,"Carbonic anhydrase 5A, mitochondrial",763.0,CA5A,9606,Homo sapiens (human),,Ki (nM),678000.0,PMID:18579385,https://www.ncbi.nlm.nih.gov/pubmed/18579385,18579385,,
17,33052,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,10154,Carbonic anhydrase 6 (CA-VI),https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=10154,P23280,Carbonic anhydrase 6,765.0,CA6,9606,Homo sapiens (human),,Ki (nM),11900.0,PMID:18579385,https://www.ncbi.nlm.nih.gov/pubmed/18579385,18579385,,
18,33053,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,1361,Carbonic anhydrase 7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1361,P43166,Carbonic anhydrase 7,766.0,CA7,9606,Homo sapiens (human),,Ki (nM),82100.0,PMID:18579385,https://www.ncbi.nlm.nih.gov/pubmed/18579385,18579385,,
19,33054,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,1233,Carbonic anhydrase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1233,Q16790,Carbonic anhydrase 9,768.0,CA9,9606,Homo sapiens (human),,Ki (nM),78700.0,PMID:18579385,https://www.ncbi.nlm.nih.gov/pubmed/18579385,18579385,,
20,33055,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,1363,Carbonic anhydrase 12,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1363,O43570,Carbonic anhydrase 12,771.0,CA12,9606,Homo sapiens (human),,Ki (nM),8800.0,PMID:18579385,https://www.ncbi.nlm.nih.gov/pubmed/18579385,18579385,,
21,33056,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,1365,Carbonic Anhydrase XIV,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1365,Q9ULX7,Carbonic anhydrase 14,23632.0,CA14,9606,Homo sapiens (human),,Ki (nM),49800.0,PMID:18579385,https://www.ncbi.nlm.nih.gov/pubmed/18579385,18579385,,
22,33057,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,1364,Carbonic Anhydrase XIII,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1364,Q9D6N1,Carbonic anhydrase 13,71934.0,Car13,10090,Mus musculus (house mouse),,Ki (nM),67000.0,PMID:18579385,https://www.ncbi.nlm.nih.gov/pubmed/18579385,18579385,,
23,33058,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,1229,Carbonic Anhydrase VB,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1229,Q9Y2D0,"Carbonic anhydrase 5B, mitochondrial",11238.0,CA5B,9606,Homo sapiens (human),,Ki (nM),355000.0,PMID:18579385,https://www.ncbi.nlm.nih.gov/pubmed/18579385,18579385,,
24,39796,338,Toxin and Toxin Target Database (T3DB),Salicylic Acid,T3D4816,Salicylic acid,http://www.t3db.ca/toxins/T3D4816,BE0000017,Prostaglandin G/H synthase 1,http://www.t3db.ca/biodb/bio_entities/BE0000017,P23219,Prostaglandin G/H synthase 1,5742.0,PTGS1,9606,Homo sapiens (human),,,,PMID:11752352|PMID:14746879|PMID:15035793|PMID:15840771|PMID:15871445|PMID:16368818|PMID:5284360,https://www.ncbi.nlm.nih.gov/pubmed/11752352|https://www.ncbi.nlm.nih.gov/pubmed/14746879|https://www.ncbi.nlm.nih.gov/pubmed/15035793|https://www.ncbi.nlm.nih.gov/pubmed/15840771|https://www.ncbi.nlm.nih.gov/pubmed/15871445|https://www.ncbi.nlm.nih.gov/pubmed/16368818|https://www.ncbi.nlm.nih.gov/pubmed/5284360,11752352|14746879|15035793|15840771|15871445|16368818|5284360,,
25,39797,338,Toxin and Toxin Target Database (T3DB),Salicylic Acid,T3D4816,Salicylic acid,http://www.t3db.ca/toxins/T3D4816,BE0000262,Prostaglandin G/H synthase 2,http://www.t3db.ca/biodb/bio_entities/BE0000262,P35354,Prostaglandin G/H synthase 2,5743.0,PTGS2,9606,Homo sapiens (human),,,,PMID:15035793|PMID:5284360|PMID:15070163|PMID:15106733|PMID:15199473|PMID:15348270,https://www.ncbi.nlm.nih.gov/pubmed/15035793|https://www.ncbi.nlm.nih.gov/pubmed/5284360|https://www.ncbi.nlm.nih.gov/pubmed/15070163|https://www.ncbi.nlm.nih.gov/pubmed/15106733|https://www.ncbi.nlm.nih.gov/pubmed/15199473|https://www.ncbi.nlm.nih.gov/pubmed/15348270,15035793|5284360|15070163|15106733|15199473|15348270,,
26,39798,338,Toxin and Toxin Target Database (T3DB),Salicylic Acid,T3D4816,Salicylic acid,http://www.t3db.ca/toxins/T3D4816,BE0000126,Aldo-keto reductase family 1 member C1,http://www.t3db.ca/biodb/bio_entities/BE0000126,Q04828,Aldo-keto reductase family 1 member C1,1645.0,AKR1C1,9606,Homo sapiens (human),,,,PMID:18045204,https://www.ncbi.nlm.nih.gov/pubmed/18045204,18045204,,
27,39799,338,Toxin and Toxin Target Database (T3DB),Salicylic Acid,T3D4816,Salicylic acid,http://www.t3db.ca/toxins/T3D4816,BE0000132,Androgen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000132,P10275,Androgen receptor,,,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
28,49977,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,5270,"Procollagen-proline,2-oxoglutarate-4-dioxygenase",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5270,P16924,Prolyl 4-hydroxylase subunit alpha-1,,,9031,Gallus gallus (chicken),,Ki (nM),2300000.0,PMID:3011801,https://www.ncbi.nlm.nih.gov/pubmed/3011801,3011801,,
29,49978,338,Therapeutic Target Database (TTD),Salicylic Acid,D07HBX,Salicyclic acid,https://idrblab.net/ttd/data/drug/details/D07HBX,T06569,Carbonic anhydrase VI (CA-VI),https://idrblab.net/ttd/data/target/details/T06569,P23280,Carbonic anhydrase 6,765.0,CA6,9606,Homo sapiens (human),Inhibitor,,,,,,,
30,49979,338,Therapeutic Target Database (TTD),Salicylic Acid,D07HBX,Salicyclic acid,https://idrblab.net/ttd/data/drug/details/D07HBX,T16987,Carbonic anhydrase XII (CA-XII),https://idrblab.net/ttd/data/target/details/T16987,O43570,Carbonic anhydrase 12,771.0,CA12,9606,Homo sapiens (human),Inhibitor,,,,,,,
31,49980,338,Therapeutic Target Database (TTD),Salicylic Acid,D07HBX,Salicyclic acid,https://idrblab.net/ttd/data/drug/details/D07HBX,T20401,Carbonic anhydrase II (CA-II),https://idrblab.net/ttd/data/target/details/T20401,P00918,Carbonic anhydrase 2,760.0,CA2,9606,Homo sapiens (human),Inhibitor,,,,,,,
32,49981,338,Therapeutic Target Database (TTD),Salicylic Acid,D07HBX,Salicyclic acid,https://idrblab.net/ttd/data/drug/details/D07HBX,T53378,Carbonic anhydrase IV (CA-IV),https://idrblab.net/ttd/data/target/details/T53378,P22748,Carbonic anhydrase 4,762.0,CA4,9606,Homo sapiens (human),Inhibitor,,,,,,,
33,49982,338,Therapeutic Target Database (TTD),Salicylic Acid,D07HBX,Salicyclic acid,https://idrblab.net/ttd/data/drug/details/D07HBX,T13201,Carbonic anhydrase I (CA-I),https://idrblab.net/ttd/data/target/details/T13201,P00915,Carbonic anhydrase 1,759.0,CA1,9606,Homo sapiens (human),Inhibitor,,,,,,,
34,49983,338,Therapeutic Target Database (TTD),Salicylic Acid,D07HBX,Salicyclic acid,https://idrblab.net/ttd/data/drug/details/D07HBX,T60529,Prostaglandin G/H synthase 1 (COX-1),https://idrblab.net/ttd/data/target/details/T60529,P23219,Prostaglandin G/H synthase 1,5742.0,PTGS1,9606,Homo sapiens (human),Inhibitor,,,,,,,
35,59279,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,10116,Rattus norvegicus (Norway rat),Salicylic acid inhibits the reaction [palmitic acid results in decreased expression of ADIPOQ mrna],,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
36,59280,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,1645,AKR1C1,https://ctdbase.org/detail.go?type=gene&acc=1645,,,1645.0,AKR1C1,9606,Homo sapiens (human),Salicylic acid inhibits the reaction [AKR1C1 protein results in decreased susceptibility to cisplatin]|benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [salicylic acid inhibits the reaction [AKR1C1 protein results in decreased susceptibility to cisplatin]],,,PMID:23165153,https://www.ncbi.nlm.nih.gov/pubmed/23165153,23165153,,
37,59281,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,1645,AKR1C1,https://ctdbase.org/detail.go?type=gene&acc=1645,,,1645.0,AKR1C1,9606,Homo sapiens (human),Salicylic acid results in decreased activity of AKR1C1 protein,,,PMID:19010312|PMID:23165153,https://www.ncbi.nlm.nih.gov/pubmed/19010312|https://www.ncbi.nlm.nih.gov/pubmed/23165153,19010312|23165153,,
38,59282,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,1646,AKR1C2,https://ctdbase.org/detail.go?type=gene&acc=1646,,,1646.0,AKR1C2,9606,Homo sapiens (human),Salicylic acid results in decreased activity of AKR1C2 protein,,,PMID:19010312,https://www.ncbi.nlm.nih.gov/pubmed/19010312,19010312,,
39,59283,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,1646,AKR1C2,https://ctdbase.org/detail.go?type=gene&acc=1646,,,1646.0,AKR1C2,9606,Homo sapiens (human),Salicylic acid results in increased expression of AKR1C2 mRNA,,,PMID:20491607,https://www.ncbi.nlm.nih.gov/pubmed/20491607,20491607,,
40,59284,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,8644,AKR1C3,https://ctdbase.org/detail.go?type=gene&acc=8644,,,8644.0,AKR1C3,9606,Homo sapiens (human),Salicylic acid results in decreased activity of AKR1C3 protein,,,PMID:19010312,https://www.ncbi.nlm.nih.gov/pubmed/19010312,19010312,,
41,59436,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,383,ARG1,https://ctdbase.org/detail.go?type=gene&acc=383,,,383.0,ARG1,10116,Rattus norvegicus (Norway rat),Salicylic acid inhibits the reaction [palmitic acid results in decreased expression of ARG1 mrna],,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
42,59437,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,9311,ASIC3,https://ctdbase.org/detail.go?type=gene&acc=9311,,,9311.0,ASIC3,10116,Rattus norvegicus (Norway rat),Salicylic acid results in decreased activity of ASIC3 protein,,,PMID:11588175,https://www.ncbi.nlm.nih.gov/pubmed/11588175,11588175,,
43,59438,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,834,CASP1,https://ctdbase.org/detail.go?type=gene&acc=834,,,834.0,CASP1,9606,Homo sapiens (human),Salicylic acid results in increased phosphorylation of CASP1 protein,,,PMID:30842373,https://www.ncbi.nlm.nih.gov/pubmed/30842373,30842373,,
44,59439,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606,Homo sapiens (human),"Salicylic acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein]",,,PMID:36416909,https://www.ncbi.nlm.nih.gov/pubmed/36416909,36416909,,
45,59440,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10116,Rattus norvegicus (Norway rat),Salicylic acid inhibits the reaction [palmitic acid results in increased expression of CCL2 mrna],,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
46,59441,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,10090,Mus musculus (house mouse),Salicylic acid results in increased expression of CXCL2 protein,,,PMID:23178550,https://www.ncbi.nlm.nih.gov/pubmed/23178550,23178550,,
47,59442,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606,Homo sapiens (human),"Salicylic acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CXCL8 protein]",,,PMID:36416909,https://www.ncbi.nlm.nih.gov/pubmed/36416909,36416909,,
48,59443,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606,Homo sapiens (human),Salicylic acid results in increased expression of CXCL8 protein,,,PMID:31734321,https://www.ncbi.nlm.nih.gov/pubmed/31734321,31734321,,
49,59444,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606,Homo sapiens (human),Potassium chloride affects the reaction [salicylic acid affects the expression of ICAM1 protein]|salicylic acid affects the expression of ICAM1 protein,,,PMID:30842373,https://www.ncbi.nlm.nih.gov/pubmed/30842373,30842373,,
50,59445,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,3593,IL12B,https://ctdbase.org/detail.go?type=gene&acc=3593,,,3593.0,IL12B,9606,Homo sapiens (human),"Salicylic acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL12B protein]",,,PMID:36416909,https://www.ncbi.nlm.nih.gov/pubmed/36416909,36416909,,
51,59580,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,10090,Mus musculus (house mouse),Salicylic acid results in increased expression of IL1A protein,,,PMID:23178550,https://www.ncbi.nlm.nih.gov/pubmed/23178550,23178550,,
52,59581,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606,Homo sapiens (human),Salicylic acid results in increased expression of IL1B protein,,,PMID:30842373,https://www.ncbi.nlm.nih.gov/pubmed/30842373,30842373,,
53,59582,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,9606,Homo sapiens (human),Salicylic acid results in decreased secretion of IL4 protein|salicylic acid results in decreased expression of IL4 mRNA,,,PMID:11238116,https://www.ncbi.nlm.nih.gov/pubmed/11238116,11238116,,
54,59583,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090,Mus musculus (house mouse),Salicylic acid inhibits the reaction [mercury results in increased expression of IL6],,,PMID:23742082,https://www.ncbi.nlm.nih.gov/pubmed/23742082,23742082,,
55,59584,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),Salicylic acid inhibits the reaction [palmitic acid results in increased expression of IL6 mrna],,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
56,59585,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,4025,LPO,https://ctdbase.org/detail.go?type=gene&acc=4025,,,4025.0,LPO,9913,Bos taurus (cattle),Salicylic acid results in decreased activity of LPO protein,,,PMID:28594102,https://www.ncbi.nlm.nih.gov/pubmed/28594102,28594102,,
57,59586,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,23764,MAFF,https://ctdbase.org/detail.go?type=gene&acc=23764,,,23764.0,MAFF,9606,Homo sapiens (human),Salicylic acid results in increased expression of MAFF mRNA,,,PMID:20491607,https://www.ncbi.nlm.nih.gov/pubmed/20491607,20491607,,
58,59587,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,9606,Homo sapiens (human),Salicylic acid results in increased activity of MPO protein,,,PMID:24060682,https://www.ncbi.nlm.nih.gov/pubmed/24060682,24060682,,
59,59588,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,4489,MT1A,https://ctdbase.org/detail.go?type=gene&acc=4489,,,4489.0,MT1A,9606,Homo sapiens (human),Salicylic acid results in increased expression of MT1A mRNA,,,PMID:20491607,https://www.ncbi.nlm.nih.gov/pubmed/20491607,20491607,,
60,59589,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),Salicylic acid inhibits the reaction [palmitic acid results in increased expression of NOS2 mrna],,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
61,59590,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,10116,Rattus norvegicus (Norway rat),Salicylic acid inhibits the reaction [palmitic acid inhibits the reaction [acetylcholine results in increased phosphorylation of NOS3 protein]],,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
62,59748,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,2908,NR3C1,https://ctdbase.org/detail.go?type=gene&acc=2908,,,2908.0,NR3C1,8022,Oncorhynchus mykiss (rainbow trout),Salicylic acid results in decreased expression of NR3C1 protein,,,PMID:16551645,https://www.ncbi.nlm.nih.gov/pubmed/16551645,16551645,,
63,59749,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,5443,POMC,https://ctdbase.org/detail.go?type=gene&acc=5443,,,5443.0,POMC,8022,Oncorhynchus mykiss (rainbow trout),Salicylic acid inhibits the reaction [POMC protein results in increased abundance of hydrocortisone],,,PMID:16551645,https://www.ncbi.nlm.nih.gov/pubmed/16551645,16551645,,
64,59750,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10116,Rattus norvegicus (Norway rat),Salicylic acid inhibits the reaction [palmitic acid results in decreased expression of PPARG mrna],,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
65,59751,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,5699,PSMB10,https://ctdbase.org/detail.go?type=gene&acc=5699,,,5699.0,PSMB10,9606,Homo sapiens (human),Salicylic acid results in increased expression of PSMB10 mRNA,,,PMID:23165153,https://www.ncbi.nlm.nih.gov/pubmed/23165153,23165153,,
66,59752,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,5698,PSMB9,https://ctdbase.org/detail.go?type=gene&acc=5698,,,5698.0,PSMB9,9606,Homo sapiens (human),Salicylic acid results in increased expression of PSMB9 mRNA,,,PMID:23165153,https://www.ncbi.nlm.nih.gov/pubmed/23165153,23165153,,
67,59753,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606,Homo sapiens (human),Salicylic acid results in decreased expression of PTGS2 mRNA,,,PMID:16936242,https://www.ncbi.nlm.nih.gov/pubmed/16936242,16936242,,
68,59754,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [salicylic acid inhibits the reaction [palmitic acid results in increased phosphorylation of RELA protein]]|salicylic acid inhibits the reaction [palmitic acid results in increased phosphorylation of RELA protein]|dorsomorphin inhibits the reaction [salicylic acid inhibits the reaction [palmitic acid results in increased phosphorylation of RELA protein]],,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
69,59755,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411.0,SIRT1,10116,Rattus norvegicus (Norway rat),[niacinamide results in decreased activity of SIRT1 protein] which results in decreased susceptibility to salicylic acid,,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
70,59756,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,6566,SLC16A1,https://ctdbase.org/detail.go?type=gene&acc=6566,,,6566.0,SLC16A1,9606,Homo sapiens (human),Salicylic acid inhibits the reaction [SLC16A1 protein results in increased uptake of lactic acid],,,PMID:15804185,https://www.ncbi.nlm.nih.gov/pubmed/15804185,15804185,,
71,59757,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,6566,SLC16A1,https://ctdbase.org/detail.go?type=gene&acc=6566,,,6566.0,SLC16A1,10116,Rattus norvegicus (Norway rat),Salicylic acid inhibits the reaction [SLC16A1 protein results in increased transport of benzoic acid],,,PMID:10714609,https://www.ncbi.nlm.nih.gov/pubmed/10714609,10714609,,
72,59905,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,55867,SLC22A11,https://ctdbase.org/detail.go?type=gene&acc=55867,,,55867.0,SLC22A11,9606,Homo sapiens (human),Salicylic acid results in decreased activity of SLC22A11 protein|slc22a11 protein results in increased uptake of salicylic acid,,,PMID:12388633,https://www.ncbi.nlm.nih.gov/pubmed/12388633,12388633,,
73,59906,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,171405,SLC22A27,https://ctdbase.org/detail.go?type=gene&acc=171405,,,171405.0,Slc22a27,10090,Mus musculus (house mouse),Salicylic acid inhibits the reaction [SLC22A27 protein alternative form results in increased uptake of carnitine]|slc22a27 protein alternative form results in increased transport of salicylic acid,,,PMID:20332632,https://www.ncbi.nlm.nih.gov/pubmed/20332632,20332632,,
74,59907,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,9356,SLC22A6,https://ctdbase.org/detail.go?type=gene&acc=9356,,,9356.0,SLC22A6,9606,Homo sapiens (human),SLC22A6 protein results in increased uptake of salicylic acid|salicylic acid results in decreased activity of SLC22A6 protein,,,PMID:12388633,https://www.ncbi.nlm.nih.gov/pubmed/12388633,12388633,,
75,59908,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,10864,SLC22A7,https://ctdbase.org/detail.go?type=gene&acc=10864,,,10864.0,SLC22A7,9606,Homo sapiens (human),Salicylic acid promotes the reaction [SLC22A7 protein results in increased export of orotic acid],,,PMID:22981274,https://www.ncbi.nlm.nih.gov/pubmed/22981274,22981274,,
76,59909,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,10864,SLC22A7,https://ctdbase.org/detail.go?type=gene&acc=10864,,,10864.0,SLC22A7,9606,Homo sapiens (human),SLC22A7 protein results in increased uptake of salicylic acid|salicylic acid results in decreased activity of SLC22A7 protein,,,PMID:12388633,https://www.ncbi.nlm.nih.gov/pubmed/12388633,12388633,,
77,59910,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,114571,SLC22A9,https://ctdbase.org/detail.go?type=gene&acc=114571,,,114571.0,SLC22A9,9606,Homo sapiens (human),SLC22A9 protein results in increased uptake of salicylic acid|salicylic acid results in decreased activity of SLC22A9 protein,,,PMID:12388633,https://www.ncbi.nlm.nih.gov/pubmed/12388633,12388633,,
78,59911,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,8022,Oncorhynchus mykiss (rainbow trout),Salicylic acid results in decreased expression of STAR mRNA,,,PMID:16551645,https://www.ncbi.nlm.nih.gov/pubmed/16551645,16551645,,
79,59912,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),"Salicylic acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein]",,,PMID:36416909,https://www.ncbi.nlm.nih.gov/pubmed/36416909,36416909,,
80,59913,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Salicylic acid inhibits the reaction [palmitic acid results in increased expression of TNF mrna],,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
81,59914,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,706,TSPO,https://ctdbase.org/detail.go?type=gene&acc=706,,,706.0,TSPO,8022,Oncorhynchus mykiss (rainbow trout),Salicylic acid results in decreased expression of TSPO mRNA,,,PMID:16551645,https://www.ncbi.nlm.nih.gov/pubmed/16551645,16551645,,
82,60072,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,7295,TXN,https://ctdbase.org/detail.go?type=gene&acc=7295,,,7295.0,TXN,9606,Homo sapiens (human),Salicylic acid results in increased expression of TXN mRNA,,,PMID:20491607,https://www.ncbi.nlm.nih.gov/pubmed/20491607,20491607,,
83,60073,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,54575,UGT1A10,https://ctdbase.org/detail.go?type=gene&acc=54575,,,54575.0,UGT1A10,9606,Homo sapiens (human),UGT1A10 protein results in increased glucuronidation of salicylic acid,,,PMID:15117964,https://www.ncbi.nlm.nih.gov/pubmed/15117964,15117964,,
84,60074,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,54659,UGT1A3,https://ctdbase.org/detail.go?type=gene&acc=54659,,,54659.0,UGT1A3,9606,Homo sapiens (human),UGT1A3 protein results in increased glucuronidation of salicylic acid,,,PMID:15117964,https://www.ncbi.nlm.nih.gov/pubmed/15117964,15117964,,
85,60075,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,54577,UGT1A7,https://ctdbase.org/detail.go?type=gene&acc=54577,,,54577.0,UGT1A7,9606,Homo sapiens (human),UGT1A7 protein results in increased glucuronidation of salicylic acid,,,PMID:15117964,https://www.ncbi.nlm.nih.gov/pubmed/15117964,15117964,,
86,60076,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,54576,UGT1A8,https://ctdbase.org/detail.go?type=gene&acc=54576,,,54576.0,UGT1A8,9606,Homo sapiens (human),UGT1A8 protein results in increased glucuronidation of salicylic acid,,,PMID:15117964,https://www.ncbi.nlm.nih.gov/pubmed/15117964,15117964,,
87,60077,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,7498,XDH,https://ctdbase.org/detail.go?type=gene&acc=7498,,,7498.0,XDH,9606,Homo sapiens (human),Salicylic acid inhibits the reaction [XDH protein results in increased abundance of reactive oxygen species],,,PMID:3840323,https://www.ncbi.nlm.nih.gov/pubmed/3840323,3840323,,
88,117725,338,IUPHAR/BPS Guide to PHARMACOLOGY,Salicylic Acid,4306,salicylic acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4306,686,ASIC3,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=686,Q9UHC3,Acid-sensing ion channel 3,9311.0,ASIC3,9606,Homo sapiens (human),,pIC50,3.6,PMID:11588175,https://www.ncbi.nlm.nih.gov/pubmed/11588175,11588175,,
